Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA—A study protocol

Medientyp: E-Artikel
Titel: Non-invasive monitoring of neoadjuvant radiation therapy response in soft tissue sarcomas by multiparametric MRI and quantification of circulating tumor DNA—A study protocol
Beteiligte: Runkel, Alexander; Braig, David; Bogner, Balazs; Schmid, Adrian; Lausch, Ute; Boneberg, Anika; Brugger, Zacharias; Eisenhardt, Anja; Kiefer, Jurij; Pauli, Thomas; Boerries, Melanie; Fuellgraf, Hannah; Kurowski, Konrad; Bronsert, Peter; Scholber, Jutta; Grosu, Anca-Ligia; Rovedo, Philipp; Bamberg, Fabian; Eisenhardt, Steffen Ulrich; Jung, Matthias
Erschienen: Public Library of Science (PLoS), 2023
Erschienen in: PLOS ONE
Sprache: Englisch
DOI: 10.1371/journal.pone.0285580
ISSN: 1932-6203
Schlagwörter: Multidisciplinary
Entstehung:
Anmerkungen:
Beschreibung: <jats:sec id="sec001"> <jats:title>Background</jats:title> <jats:p>Wide resection remains the cornerstone of localized soft-tissue sarcomas (STS) treatment. Neoadjuvant radiation therapy (NRT) may decrease the risk of local recurrences; however, its effectiveness for different histological STS subtypes has not been systematically investigated. The proposed prospective study evaluates the NRT response in STS using liquid biopsies and the correlation of multiparametric magnetic resonance imaging (mpMRI) with histopathology and immunohistochemistry.</jats:p> </jats:sec> <jats:sec id="sec002"> <jats:title>Methods</jats:title> <jats:p>Patients with localized high-grade STS, who qualify for NRT, are included in this study.</jats:p> </jats:sec> <jats:sec id="sec003"> <jats:title>Liquid biopsies</jats:title> <jats:p>Quantification of circulating tumor DNA (ctDNA) in patient blood samples is performed by targeted next-generation sequencing. Soft-tissue sarcoma subtype-specific panel sequencing in combination with patient-specific exome sequencing allows the detection of individual structural variants and point mutations. Circulating free DNA is isolated from peritherapeutically collected patient plasma samples and ctDNA quantified therein. Identification of breakpoints is carried out using FACTERA. Bioinformatic analysis is performed using samtools, picard, fgbio, and the MIRACUM Pipeline.</jats:p> </jats:sec> <jats:sec id="sec004"> <jats:title>mpMRI</jats:title> <jats:p>Combination of conventional MRI sequences with diffusion-weighted imaging, intravoxel-incoherent motion, and dynamic contrast enhancement. Multiparametric MRI is performed before, during, and after NRT. We aim to correlate mpMRI data with the resected specimen’s macroscopical, histological, and immunohistochemical findings.</jats:p> </jats:sec> <jats:sec id="sec005"> <jats:title>Results</jats:title> <jats:p>Preliminary data support the notion that quantification of ctDNA in combination with tumor mass characterization through co-registration of mpMRI and histopathology can predict NRT response of STS.</jats:p> </jats:sec> <jats:sec id="sec006"> <jats:title>Clinical relevance</jats:title> <jats:p>The methods presented in this prospective study are necessary to assess therapy response in heterogeneous tumors and lay the foundation of future patient- and tumor-specific therapy concepts. These methods can be applied to various tumor entities. Thus, the participation and support of a wider group of oncologic surgeons are needed to validate these findings on a larger patient cohort.</jats:p> </jats:sec>
Zugangsstatus: Freier Zugang

Nur in Feld suchen:

Zuletzt gesuchte Begriffe: